Tag: lung cancer

Featured Health & Pharmaceuticals

Actavis launches Gemcitabine on patent expiry in EU markets

March 13, 20092 min read

The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone

Actavis, bladder cancer, breast cancer, EU, Gemcitabine, hospital business, lung cancer, oncology treatment, pancreatic cancer, patent expiry, treatment of cancer

You May Have Missed

IT & Technology

Norwegian AI Startup Aida Makes Waves at UK Business Expos

May 7, 2025May 7, 2025

IT & Technology Software

Aida Social Powers 2025 Hashtag Events Business Shows Across UK and Ireland as Official Social Media Sponsor

April 10, 2025April 10, 2025

$Pipar\TBWA Named Advertising Agency of the Year for the Second Consecutive Year$

Retail & Services

Pipar\TBWA Named Advertising Agency of the Year for the Second Consecutive Year

March 13, 2025March 13, 2025

Society Travel & Leisure

QUIRKY CAMPERS UNVEILS DEDICATED GLASTONBURY 2025 CAMPERVAN FLEET

March 13, 2025